Literature DB >> 17692373

Exogenous nitric oxide triggers classic ischemic preconditioning by preventing intracellular Ca2+ overload in cardiomyocytes.

Ophra Rickover1, Tova Zinman, Doron Kaplan, Asher Shainberg.   

Abstract

The involvement of nitric oxide (NO) in the late phase of ischemic preconditioning is well established. However, the role of NO as a trigger or mediator of "classic preconditioning" remains to be determined. The present study was designed to investigate the effects of NO on calcium homeostasis in cultured newborn rat cardiomyocytes in normoxia and hypoxia. We found that treatment with the NO donor, sodium nitroprusside (SNP) induced a sustained elevation of intracellular calcium level ([Ca(2+)](i)) followed by a decrease to control levels. Elevation of extracellular calcium, which generally occurs during ischemia, caused an immediate increase in [Ca(2+)](i) and arrhythmia in cultures of newborn cardiomyocytes. Treatment with SNP decreased [Ca(2+)](i) to control levels and re-established synchronized beating of cardiomyocytes. A decrease in extracellular [Na(+)], which inhibits the Na(+)/Ca(2+) exchanger, did not prevent [Ca(2+)](i) reduction by SNP. In contrast, application of thapsigargin, an inhibitor of sarcoplasmic reticulum Ca(2+)-ATPase (SERCA2a), increased [Ca(2+)](i), and in its presence, SNP did not reduce [Ca(2+)](i), indicating that Ca(2+) reduction is achieved via activation of SERCA2a. The results obtained suggest that activation of SERCA2a by SNP increases Ca(2+) uptake into the sarcoplasmic reticulum (SR) and prevents cytosolic Ca(2+) overload, which might explain the protective effect of SNP from hypoxic damage.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17692373     DOI: 10.1016/j.ceca.2007.06.003

Source DB:  PubMed          Journal:  Cell Calcium        ISSN: 0143-4160            Impact factor:   6.817


  8 in total

1.  The role of nitric oxide, superoxide and peroxynitrite in the anti-arrhythmic effects of preconditioning and peroxynitrite infusion in anaesthetized dogs.

Authors:  Attila Kiss; László Juhász; György Seprényi; Krisztina Kupai; József Kaszaki; Agnes Végh
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

2.  Ischemic preconditioning attenuates mitochondrial localization of PTEN induced by ischemia-reperfusion.

Authors:  Lingyun Zu; Xiaoxu Zheng; Bing Wang; Nirmal Parajuli; Charles Steenbergen; Lewis C Becker; Zheqing P Cai
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-03-18       Impact factor: 4.733

3.  Myocardial NOS activity and connexin-43 expression in untreated and omega-3 fatty acids-treated spontaneously hypertensive and hereditary hypertriglyceridemic rats.

Authors:  Jana Radosinska; Barbara Bacova; Iveta Bernatova; Jana Navarova; Anna Zhukovska; Angela Shysh; Ludmila Okruhlicova; Narcis Tribulova
Journal:  Mol Cell Biochem       Date:  2010-10-21       Impact factor: 3.396

4.  Barbaloin inhibits ventricular arrhythmias in rabbits by modulating voltage-gated ion channels.

Authors:  Zhen-Zhen Cao; You-Jia Tian; Jie Hao; Pei-Hua Zhang; Zhi-Pei Liu; Wan-Zhen Jiang; Meng-Liu Zeng; Pei-Pei Zhang; Ji-Hua Ma
Journal:  Acta Pharmacol Sin       Date:  2017-10-26       Impact factor: 6.150

Review 5.  Myocardial protection by nitrite.

Authors:  John W Calvert; David J Lefer
Journal:  Cardiovasc Res       Date:  2009-02-27       Impact factor: 10.787

Review 6.  Roles of the nitric oxide signaling pathway in cardiac ischemic preconditioning against myocardial ischemia-reperfusion injury.

Authors:  Punate Weerateerangkul; Siriporn Chattipakorn; Nipon Chattipakorn
Journal:  Med Sci Monit       Date:  2011-02

7.  Mechanisms of the beneficial actions of ischemic preconditioning on subcellular remodeling in ischemic-reperfused heart.

Authors:  By Alison L Müller; Naranjan S Dhalla
Journal:  Curr Cardiol Rev       Date:  2010-11

8.  Effects of the NO donor sodium nitroprusside on oxygen consumption and energetics in rabbit myocardium.

Authors:  Mark Hünlich; Gerd Hasenfuss
Journal:  Basic Res Cardiol       Date:  2009-02-03       Impact factor: 17.165

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.